577 filings
Page 4 of 29
8-K
fq1z7uc8ee44790gb
9 Nov 20
Altimmune Announces Third Quarter 2020 Financial Results
4:07pm
8-K
yd9e ysrvh
25 Sep 20
Submission of Matters to a Vote of Security Holders
4:05pm
S-8
607ddr
21 Aug 20
Registration of securities for employees
4:05pm
8-K
982ddd4l5u xfw0i
11 Aug 20
Altimmune Announces Second Quarter 2020 Financial Results and Provides a Business Update
4:07pm
8-K/A
kr06v
16 Jul 20
Departure of Directors or Certain Officers
4:57pm
8-K
pidbfmphu egd6
16 Jul 20
Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
4:38pm
424B5
fds4h
14 Jul 20
Prospectus supplement for primary offering
9:54pm
424B5
bxhow88y1e8itben1n9
13 Jul 20
Prospectus supplement for primary offering
4:06pm
8-K
jyeua6gpk13 d1q8ghkw
13 Jul 20
AdCOVID stimulated both strong serum neutralizing activity and potent mucosal immunity (IgA) in the respiratory tract
7:11am
424B5
8r502m80tj92iz7jum
1 Jun 20
Prospectus supplement for primary offering
7:18am
8-K
v5fwoo
1 Jun 20
Altimmune Launches Clinical Trial ofT-COVIDTM, an Investigational Intranasal
7:07am
8-K
e2q3hev589j
13 May 20
Altimmune Announces First Quarter 2020 Financial Results and Provides a Business Update
5:20pm
8-K
4oq0z3gh
12 May 20
Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of Directors
7:30am
8-K
23tjas asaeptc195l
8 Apr 20
Entry into a Material Definitive Agreement
8:00am
8-K
2jql7kh8mqj2tlsfvx
27 Mar 20
Entry into a Material Definitive Agreement
4:08pm
424B5
d6kzkhnsiclz
27 Mar 20
Prospectus supplement for primary offering
7:47am